Efficacy of Muller's Muscle and Conjunctiva Resection With or Without Tarsectomy for the Treatment of Severe Involutional Blepharoptosis. Ophthalmic Plast Reconstr Surg 2017;33(4):273-278
Date
07/19/2016Pubmed ID
27429227Pubmed Central ID
PMC5236006DOI
10.1097/IOP.0000000000000748Scopus ID
2-s2.0-84978782658 (requires institutional sign-in at Scopus site) 41 CitationsAbstract
PURPOSE: To determine if Muller's muscle and conjunctiva resection with or without tarsectomy is an efficacious procedure for the treatment of severe involutional blepharoptosis.
METHODS: A retrospective chart review was performed for all consecutive patients with severe involutional blepharoptosis during a 12-year period treated by a single surgeon (AMP) with a Muller's muscle and conjunctiva resection with or without tarsectomy. The inclusion criteria was good levator function (≥10 mm eyelid excursion), adequate response to phenylephrine (change in eyelid height ≥1.5 mm), and severe involutional blepharoptosis (margin-to-reflex-distance-1 ≤0 mm).
RESULTS: One hundred eyelids of 69 patients were identified that met the inclusion criteria. Mean preoperative margin-to-reflex-distance-1 was -0.65 mm and mean postoperative margin-to-reflex-distance-1 was 3.00 mm for all patients. For patients treated with Muller's muscle and conjunctiva resection without tarsectomy, mean preoperative and postoperative margin-to-reflex-distance-1 was -0.51 mm and 2.98 mm with 97.5% of the patients obtaining a lift greater than 1.5 mm.
CONCLUSIONS: The results demonstrate that Muller's muscle and conjunctiva resection with or without tarsectomy does provide another alternative to the surgeon for the management of severe involutional blepharoptosis.
Author List
Patel RM, Aakalu VK, Setabutr P, Putterman AMAuthor
Vinay Kumar Aakalu MPH, MD Chair, Professor in the Ophthalmology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdultAged
Aged, 80 and over
Blepharoplasty
Blepharoptosis
Conjunctiva
Eyelids
Female
Follow-Up Studies
Forecasting
Humans
Male
Middle Aged
Oculomotor Muscles
Retrospective Studies
Severity of Illness Index
Treatment Outcome
Young Adult
